My uncle has fathered his first children and has been worrying lately about the possibility of being separated from them. He’s asked me to look around the internet to see if I can come up with any information on where he might find someone who will implant a GPS device into his children. I’m coming up empty handed so I thought maybe you guys will have some more information for me.
Thanks!
Gadgets And Their Importance In Our Life

Gadgets are electronically simplified applications that make work easy. They play a significant role in the common man’s life and we have grown so used to it that it becomes very difficult for us to think of daily life chores in the absence of gadgets. Ranging from a washing machine, a chimney or an electric hub, the churner or simply the television set; gadgets have invaded each and every part of our life and have proved themselves to be useful.
Gadgets and their importance
1. Gadgets increase our efficiency. Before the invention of the telephone or the more recent e-mails, sending messages and letters would take days to reach its destination. The soft wares used for application in the internet and the telecommunication are nothing but technical gadgets. These gadgets actually have increased human productivity in terms of work and made the world a better place to live in.
2. A gadget brings joy to the family. With the advent of webcam and other video accessories, staying away from family and friends is no longer painful. These gadgets can make distant things come near and makes human accessibility very easy.
3. Gadgets make things compact- Take the example of a Swiss Army knife. It can be used as a spoon, knife, twizzer, bottle opener, fork etc. In a single gadget a user can get the function of more than one product.
4. They help in saving space. Initially in the early years of telecommunication the wired handsets could be positioned at a prescribed position only for connectivity. With advent in technology, mobiles were invented that allowed users the freedom to access calls when moving around. With a blackberry one can also avail internet facilities when moving around.
5. Gadgets are fun! I-pods, music systems, video games, DVD and most important of all the popular idiot box of ours-“TV” need no introduction as to how enjoyable have they made our lives. These technical gadgets have the power to make us smile by having access to our emotions and needs. They are instruments that can ward off the feelings of loneliness. They are so fun that it actually becomes very essential to integrate them with our lives.
So, gadgets not only make our lives easier but also save our money and precious time. Buying a single gadget will give us the functions of many. This makes gadgets cheap and affordable. It can therefore be concluded that gadgets are not only important because they make our lives easy but also because we can play with them.
Pleasure Satellite
Product Description
Nevan’s life is nothing but duty and honor. The eldest son of a prestigious House, he has a life mapped out ahead of him, including mating a woman for whom he feels nothing but brotherly affection. But then one night he discovers a woman who makes his blood boil and his body hard.Seena has known nothing but blood and pain in her life. A fighter for the BloodRing, she is nothing more than spectacle, her life and death meaningless except as entertainment for the mas… More >>
Dual iPhone / iPod Splitter Cable. Charge up to Two Apple Devices At Once From a Single USB Port
- iPod / iPhone dual 2-in-1 USB Cable
- Charge up to 2 iPod and/or iPhones at once (Sync one)
- USB 2.0 High Quality Cable
- Charge 2 devices using your existing wall or car charger
- 2 Year Warranty
Product Description
This 2-in-1 Dual iPod/iPhone charger is perfect for families, roommates, Apple enthusiasts, and more! Use one cable to charge two iPhone or iPods at once. Save space and stay organized with this great accessory…. More >>
Dual iPhone / iPod Splitter Cable. Charge up to Two Apple Devices At Once From a Single USB Port
Global Clinical Trial Market 2007 to 2010 Key Therapeutic Categories Country Wise Metrics

Report Summary
Clinical trials market now witness a paradigm shift. NaA¯ve heterogeneous patient populations in the developing nations is opening up new avenues for the clinical trials market. Developing countries also offer faster go to market which is triggering major pharmaceutical companies to direct their investment in these regions. Apart from this, stringent regulations and tight R&D budgets in the Pharma-Biotech industry are also forcing companies to move to east. This scenario has further boosted the alliances between the pharma-biotech companies and the clinical research organizations, with the latter accounting for major chunk of the trials conducted
Browse all : Market Research Reports
Today, emerging countries account for the largest share of the phase II/III (prime stages) clinical trials conducted globally with major focus on oncology, Alzheimer’s, metabolic and cardiovascular diseases. Support from the respective government bodies is one of the major factors affecting the clinical trials market. Clinical trials sponsored by the industry have a much higher share in the market as compared to government organizations.
The key players (Clinical Research Organizations) in the market include Chiltern, Omnicare, PPD, Parexel, Kendle and Quintles.
This research report categorizes the Global Clinical Trials Market on the basis of phases, indications, and study design analyzing trends in each. Each section will provide market data, market drivers, trends and opportunities, key players, and competitive outlook. This report will also provide more than 20 company profiles.
Table of Contents
1 Introduction
1.1 Key Take-aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
2 Executive Summary
2.1 Overview of the Market
2.2 Key Findings
3 Market Overview
3.1 Market Definition
3.2 Drivers
3.2.1 Globalizing drug development activities
3.2.2 Rise in r&d investments expected to boost the clinical trials market
3.2.3 High disease prevalence in emerging countries
3.3 Restraints
3.3.1 Longer approval time for clinical trials – a cause of concern for major pharmaceutical-biotechnology players
3.4 Burning Issues
3.4.1 Out skirting boundaries of medical ethics
3.5 Winning Imperatives
3.5.1 Leveraging online resources to increase patient recruitment rates in clinical trials
3.6 Country Comparison
3.7 Industry Trends
3.7.1 Engaging clinical trials in emerging countries & low cost CRO’s prove to be compelling options in times of drug patent expiry
3.7.2 CROs leveraging the benefits of emerging markets
3.7.3 Changing CRO business models
3.7.3.1 Full service model
3.7.3.2 Hourly billing model
3.7.3.3 Full time equivalent model (FTE)
3.7.3.4 Fixed price model
3.7.4 Prevalence of preferred provider relationships
3.7.5 Shift towards patient centric clinical trials due to technical advances
3.8 Global Clinical Trials Market
3.8.1 Offshoring & outsourcing
4 Clinical Trials Market, by Types
4.1 Introduction
4.1.1 Clinical trials market, by study phases
4.1.1.1 Preclinical studies
4.1.1.2 Phase I trials
4.1.1.3 Phase II trials
4.1.1.4 Phase I/II
4.1.1.5 Phase II/III
4.1.1.6 Phase III trials
4.1.2 Clinical trials market, by study designs
4.1.2.1 Observational studies
4.1.2.2 Interventional studies
4.1.2.3 Expanded access trials
4.1.3 Clinical trials market, by indications
5 Geographic Analysis
5.1 North America
5.1.1 U.S.
5.1.1.1 Regulatory environment
5.1.1.2 Clinical trials registry
5.1.1.3 Government support
5.1.2 Canada
5.1.2.1 Regulatory environment
5.1.2.2 Clinical trials registry
5.1.2.3 Government support
5.2 Europe
5.2.1 UK
5.2.1.1 Regulatory environment
5.2.1.2 Clinical trials registry
5.2.1.3 Government support
5.2.2 Germany
5.2.2.1 Regulatory environment
5.2.2.2 Clinical trials registry
5.2.2.3 Government support
5.2.3 Italy
5.2.3.1 Regulatory environment
5.2.3.2 Clinical trials registry
5.2.3.3 Government support
5.2.4 France
5.2.4.1 Regulatory environment
5.2.4.2 Clinical trials registry
5.2.4.3 Support rendered by the government
5.2.5 Spain
5.2.5.1 Regulatory environment
5.2.5.2 Clinical trials registry
5.2.5.3 Government support
5.2.6 Poland
5.2.6.1 Regulatory environment
5.2.6.2 Clinical trials registry
5.2.6.3 Support rendered by the Government
5.2.7 Russia
5.2.7.1 Regulatory environment
5.2.7.2 Clinical trials registry
5.2.7.3 Support rendered by the Government
5.2.8 Turkey
5.2.8.1 Regulatory environment
5.2.8.2 Clinical trials registry
5.2.8.3 Government support
5.2.9 Ukraine
5.2.9.1 Regulatory environment
5.2.9.2 Clinical trials registry
5.2.9.3 Support rendered by the Government
5.3 Asia
5.3.1 China
5.3.1.1 Clinical trials registry
5.3.1.2 Government support
5.3.2 India
5.3.2.1 Regulatory environment
5.3.2.2 Clinical trials registry
5.3.2.3 Government support
5.3.3 South Korea
5.3.3.1 Regulatory environment
5.3.3.2 Clinical trials registry
5.3.3.3 Government support
5.4 Latin America
5.4.1 Brazil
5.4.1.1 Regulatory environment
5.4.1.2 Clinical trials registry
5.4.1.3 Government support
5.4.2 Mexico
5.4.2.1 Regulatory environment
5.4.2.2 Clinical trials registry
5.4.2.3 Government support
5.4.3 Argentina
5.4.3.1 Regulatory environment
5.4.3.2 Clinical trials registry
5.4.3.3 Government support
6 Competitive Landscape
6.1 Introduction
Related Reports:
Clinical Trial Recruitment in Dermatology – Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers – http://www.reportsnreports.com/reports/130633-clinical-trial-recruitment-in-dermatology-most-trials-focus-on-.html

